Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

BACKGROUND: Immune checkpoint inhibitors targeting programmed cell death 1 (PD1) or its ligand (PD-L1) showed activity in several cancer types. METHODS: We performed immunohistochemistry for CD3, CD8, CD20, HLA-DR, phosphatase and tensin homolog (PTEN), PD-1, and PD-L1 and pyrosequencing for assessm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Berghoff, Anna Sophie, Kiesel, Barbara, Widhalm, Georg, Rajky, Orsolya, Ricken, Gerda, Wöhrer, Adelheid, Dieckmann, Karin, Filipits, Martin, Brandstetter, Anita, Weller, Michael, Kurscheid, Sebastian, Hegi, Monika E., Zielinski, Christoph C., Marosi, Christine, Hainfellner, Johannes A., Preusser, Matthias, Wick, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2015
Assuntos:
Basic and Translational Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490866/
https://ncbi.nlm.nih.gov/pubmed/25355681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou307
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares